High density lipoprotein and coronary heart disease: insights from mutations leading to low high density lipoprotein

Curr Opin Lipidol. 1997 Aug;8(4):219-24. doi: 10.1097/00041433-199708000-00005.

Abstract

Hypoalphalipoproteinemia can result from defects in the genes encoding apolipoprotein A-I, the major protein component of HDL, or enzymes that are critical for the formation/maturation of mature HDL. Recent information contradicts earlier findings, suggesting that most of the affected subjects are at increased risk of developing coronary heart disease, independent of the mutated gene. A possible exception is represented by mutations in the apolipoprotein A-I gene leading to structural variants, that might even exert a protective effect against atherosclerosis.

Publication types

  • Review

MeSH terms

  • Apolipoprotein A-I / genetics
  • Coronary Disease / blood*
  • Coronary Disease / etiology
  • Coronary Disease / genetics*
  • Humans
  • Lipoprotein Lipase / genetics
  • Lipoproteins, HDL / genetics
  • Lipoproteins, HDL / metabolism*
  • Mutation*
  • Phosphatidylcholine-Sterol O-Acyltransferase / genetics
  • Tangier Disease / genetics

Substances

  • Apolipoprotein A-I
  • Lipoproteins, HDL
  • Phosphatidylcholine-Sterol O-Acyltransferase
  • Lipoprotein Lipase